Cholecystectomy is amongst the most common surgical operations performed worldwide. Surgical candidates are treated for biliary pathologies, such as biliary cholic, cholecystitis and gallstone pancreatisis. The universal establishment of safe cholecystectomy is a complex process that relies not only on the operation itself, but also on various other factors such as promoting adequate training, improving hospital infrastructure, and enhancing peri-operative patient care. There remains a paucity of evidence around the variations of safe provision of laparoscopic surgery for gallbladder disease interntionally, including low- and middle-income countries.
To bridge this knowledge gap, the Global Evaluation of Cholecystectomy Knowledge and Outcomes (GECKO) study (GlobalSurg 4) will be an international collaborative effort, delivered by the GlobalSurg network, that will allow contemporaneous data collection on the quality of cholecystectomies using measures covering infrastructure, care processes and outcomes. It will be disseminated via contacts from the National Institute for Health and Care Research (NIHR) Global Surgery unit, leading emergency general surgeons and specialist organisations.
The study will span between 31st July 2023 to 19th November 2023, with follow-up at 30-day and one-year postoperatively
DETAILS
https://www.globalsurgeryunit.org/clinical-trials-holding-page/project-gecko/
REGISTRATION FORM
https://redcap.globalsurg.org/surveys/?s=3WFTHDRK798J9DDN
We already registered our hospital.
Stefano Rossi
Emergency and general surgery
San Filippo Neri
ASL Roma1
Dr Biagio Picardi hospital Lead
I am an internist. My experience includes cases as you consider in the discussion, but also functional disordesrs of the gallbladder diagnosed by an oral cholecystography (not used any more), absence of lithiasis, but mainly bowel functional disorders prematurely operated in emergency context with no US or alarm or inflamatory signs, similarly to appendix problems. In Mexico there are some regions with no ultrasound units, so not able to make an optimal differential diagnosis
Dear all, to date we have 1532 centres registered across 126 countries. This is very positive and everyone seems to be progressing well!
And here are a list of countries with no leads, does anyone know of colleagues from these countries, especially Africa?
Andorra
Denmark
Liechtensein
Malta
Moldova
Monaco
Montenegro
San Marino
Slovak Republic
Angola
Cabo Verde
Central African Republic
Chad
Comoros
Congo
Côte d’Ivoire
Democratic Republic of the Congo
Djibouti
Equatorial Guinea
Eritrea
Eswatini
Gambia
Guinea
Lesotho
Madagascar
Malawi
Mali
Mauritania
Mauritius
Niger
Sao Tome and Principe
Senegal
Seychelles
Sierra Leone
South Sudan
Togo
Zimbabwe
Bermuda
Suriname
Trinidad and Tobago
Brunei Darussalam
Cambodia
Fiji
Korea, DPR (North)
Korea, Republic (South)
Laos
Marshall Islands
Micronesia
Myanmar
Nauru
Palau
Solomon Islands
Taiwan
Timor-Leste
Vanuatu
Iraq
Kyrgyzstan
Lebanon
Tajikistan
Turkmenistan
Uzbekistan
- Badges
- Science topic
- Similar topics
- Biological Science
- Molecular Cell Biology
- Culture Cells
- Cell Line